急性胆源性胰腺炎内镜治疗的临床对比研究  

Clinical contrast study of endoscopic treatment for acute biliary pancreatitis

作　　者：陈晓琴[1] 吴静[1] 刘雄昌 

机构地区：[1]兰州大学附属第一医院消化内科,甘肃省兰州市730000 [2]兰州市第一人民医院,甘肃省兰州市730050

出　　处：《世界华人消化杂志》2007年第3期298-301,共4页World Chinese Journal of Digestology

摘　　要：目的:通过对比观察给予不同治疗方案的3组急性胆源性胰腺炎(ABP)患者,探讨ABP经内镜治疗的优劣.方法:将119例ABP(包括SABP)患者分为内镜组(40例)、药物组(42例)、手术组(37例).对比观察3组患者治疗后症状、实验室指标恢复情况、并发症发生率、死亡率以及住院天数.结果:内镜组总并发症发生率12.5%(5/40),死亡率5.0%(2/40).手术组并发症发生率29.7%(11/37),死亡率5.4%(2/37);保守组并发症发生率23.8%(10/42),死亡率7.1%(3/42).在3组SABP中,内镜组患者在症状恢复时间、实验室指标恢复时间、及住院天数方面较手术组及保守组均明显缩短、并发症发生率较手术组及保守组均降低(P<0.05).结论:内镜治疗ABP(尤其SABP)是一项较安全、有效、经济简便、并发症少、可重复操作的治疗措施,值得临床大力推广.AIM： To explore the value of endoscopic treatment for acute biliary pancreatitis （ABP）. METHODS： A total of 119 ABP （including severe ABP） patients were treated with endoscopy （n=40）, drugs （n = 42）, and operation （n=37）, respectively. The symptoms, laboratory indexes, rates of complications and deaths as well as inhospital time were comparatively analyzed between the three groups. RESULTS： The rates of complications and deaths were 12.5% （5/40） and 5.0% （2/40） in endoscopic treatment group, 29.7% （11/37） and 5.4% （2/37） in surgical treatment group, and 23.8% （10/42） and 7.1% （3/42） in drug treatment group, respectively. The symptoms, laboratory indexes, rates of complications and deaths as well as in-hospital time were obviously improved in comparison with those in the other two groups （P 〈 0.05）. CONCLUSION： Endoscopic treatment for ABP, especially SABP, is effective, safe, economical,simple and convenient, with fewer complications.

关 键 词：急性胆源性胰腺炎 内镜 逆行胰胆管造影 鼻胆管引流 内镜下乳头括约肌切开术 

分 类 号：R576[医药卫生—消化系统]